Compare Illumina, Inc. (ILMN) vs Workday Inc (WDAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Workday Inc — how do they compare? Illumina, Inc. trades at $190.95 (market cap $29.12B), while Workday Inc trades at $174.01 (market cap $44.77B). The key difference: Workday Inc is the larger of the two by market cap, and Illumina, Inc. is trading nearer its 52-week high, Workday Inc nearer its low. Which is the better fit depends on your goals.
| ILMN | WDAY | |
|---|---|---|
Market Cap | $29.12B | $44.77B |
Sector | Health | Technology |
52-Week High | $205.10 | $247.69 |
52-Week Low | $91.00 | $112.55 |
Enterprise Value | $30.48B | $44.22B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $191.32, down 0.25% on the day, with a bullish earnings trend after beating Q2 2026 estimates. The stock shows strong profitability with a net margin of 18.34% and positive cash flow, though technical indicators signal near-term bearish pressure. Recent news highlights institutional buying and AI partnerships boosting growth prospects.
Outlook remains positive with a consensus price target of $201.58, offering ~5% upside, supported by solid fundamentals and analyst optimism. Risks include high valuation multiples and competitive pressures in genomics. The stock presents a growth opportunity with manageable near-term volatility.
Workday (WDAY) trades at $174.5, down 5.26% over 24 hours, with a bullish technical signal from moving averages but overbought RSI readings. The company shows strong revenue growth, reaching $8.45B in 2025, with consistent earnings beats and a high gross margin of 75.77%. Recent news highlights product launches like Workday Adaptive Planning's FedRAMP authorization and an AI-native learning platform, reinforcing its enterprise software leadership.
Outlook remains positive with robust fundamentals and analyst support, though elevated valuation ratios like a P/E of 56.47 pose risks. Key opportunities include AI-driven growth in HR and finance software, while risks involve competitive pressures and market volatility. The consensus price target of $153.33 suggests caution near current levels, but long-term growth prospects are solid.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Workday Inc
Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 12,000 employees.
Read more on WDAY →
